Filana Therapeutics, Inc.
FLNA
$1.42
-$0.01-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 17.61% | -16.03% | 75.56% | -88.97% | 15.20% |
| Total Depreciation and Amortization | -33.79% | 180.15% | -39.91% | -0.91% | -15.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.28% | 22.08% | -3.91% | -12.33% | -9.04% |
| Change in Net Operating Assets | 3.08% | -5,666.04% | -99.85% | 420.66% | 116.69% |
| Cash from Operations | 8.92% | -56.70% | -25.75% | 56.36% | 81.50% |
| Capital Expenditure | -- | -526.25% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -526.25% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -90.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 84.50% | -- | -- | -- | -- |
| Cash from Financing | 84.50% | -- | -- | -100.00% | -90.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.59% | -67.88% | -27.37% | 56.01% | 81.38% |